Drug Type Bispecific antibody |
Synonyms CRPE7A2 |
Target |
Action inhibitors |
Mechanism E7 inhibitors(HPV E7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HPV16 Infection | Discovery | China | 25 Jul 2022 | |
| Uterine Cervical Cancer | Discovery | China | 25 Jul 2022 |






